SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Schwartz AV 2003 Diabetes mellitus: Does it affect bone? Calcif Tissue Int 73: 515519.
  • 2
    Inzerillo AM, Epstein S 2004 Osteoporosis and diabetes mellitus. Rev Endocr Metab Disord 5: 261268.
  • 3
    Leidig-Bruckner G, Ziegler R 2001 Diabetes mellitus—a risk for osteoporosis? Exp Clin Endocrinol Diabetes 109(Suppl 2): S493S514.
  • 4
    Nicodemus KK, Folsom AR, Iowa Women's Health Study 2001 Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24: 11921197.
  • 5
    Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR 1998 Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 11: 413419.
  • 6
    Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Francese A 2002 The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 58: 266272.
  • 7
    Pascual J, Argente J, Lopez MB, Munoz M, Martinez G, Vazquez MA, Jodar E, Perez-Cano R, Hawkins F 1998 Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset. Calcif Tissue Int 62: 3135.
  • 8
    Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T 2003 Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 26: 23652369.
  • 9
    Ingberg CM, Palmer M, Aman J, Arvidsson B, Schvarcz E, Berne C 2004 Body composition and bone mineral density in long-standing type 1 diabetes. J Intern Med 255: 392398.
  • 10
    Bridges MJ, Moochhala SH, Barbour J, Kelly CA 2005 Influence of diabetes on peripheral bone mineral density in men: A controlled study. Acta Diabetol 42: 8286.
  • 11
    Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, Pardo MD, Gonzalez AG, Luna JD, Requena ME, Diosdado MA 2001 Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract 7: 346351.
  • 12
    Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG 2000 Osteopenia in insulin-dependent diabetes mellitus: Prevalence and aspects of pathophysiology. J Endocrinol Invest 23: 295303.
  • 13
    Tuominen JT, Impivaara O, Puukka P, Ronnemaa T 1999 Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22: 11961200.
  • 14
    Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, Ralston SH 1998 Bone mineral density, collagen type 1 α 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 41: 13141320.
  • 15
    Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS 2006 Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 29: 306311.
  • 16
    Marshall D, Johnell O, Wedel H 1996 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312: 12541259.
  • 17
    Rozadilla A, Nolla JM, Montana E, Fiter J, Gomez-Vaquero C, Soler J, Roig-Escofet D 2000 Bone mineral density in patients with type 1 diabetes mellitus. Joint Bone Spine 67: 215218.
  • 18
    Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD 1996 Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int 58: 316319.
  • 19
    Rix M, Andreassen H, Eskildsen P 1999 Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 22: 827831.
  • 20
    Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, Garcia-Cervigon AG 2000 Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: A prospective study. Osteoporos Int 11: 455459.
  • 21
    Clausen P, Feldt-Rasmussen B, Jacobsen P, Rossing K, Parving HH, Nielsen PK, Feldt-Rasmussen U, Olgaard K 1997 Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients. Diabet Med 14: 10381043.
  • 22
    Olmos JM, Perez-Castrillon JL, Garcia MT, Garrido JC, Amado JA, Gonzalez-Macias J 1994 Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone Miner 26: 18.
  • 23
    Lunt H, Florkowski CM, Cundy T, Kendall D, Brown LJ, Elliot JR, Wells JE, Turner JG 1998 A population-based study of bone mineral density in women with longstanding type 1 (insulin dependent) diabetes. Diabetes Res Clin Pract 40: 3138.
  • 24
    Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL 2005 Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289: E735E745.
  • 25
    Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devlin VJ, Beyer MM 1988 The mineral and mechanical properties of bone in chronic experimental diabetes. J Orthop Res 6: 317323.
  • 26
    Maor G, Karnieli E 1999 The insulin-sensitive glucose transporter (GLUT4) is involved in early bone growth in control and diabetic mice, but is regulated through the insulin-like growth factor I receptor. Endocrinology 140: 18411851.
  • 27
    Kitamura T, Kitamura Y, Nakae J, Giordano A, Cinti S, Kahn CR, Efstratiadis A, Accili D 2004 Mosaic analysis of insulin receptor function. J Clin Invest 113: 209219.
  • 28
    Akune T, Ogata N, Hoshi K, Kubota N, Terauchi Y, Tobe K, Takagi H, Azuma Y, Kadowaki T, Nakamura K, Kawaguchi H 2002 Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 159: 147156.
  • 29
    Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H 2000 Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105: 935943.
  • 30
    Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE 2006 Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39: 494504.
  • 31
    Bouxsein ML, Rosen CJ, Turner CH, Ackert CL, Shultz KL, Donahue LR, Churchill G, Adamo ML, Powell DR, Turner RT, Muller R, Beamer WG 2002 Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo. J Bone Miner Res 17: 570579.
  • 32
    Bouillon R, Bex M, van Herck E, Laureys J, Dooms L, Lesaffre E, Ravussin E 1995 Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80: 11941202.
  • 33
    Horcajada-Molteni MN, Chanteranne B, Lebecque P, Davicco MJ, Coxam V, Young A, Barlet JP 2001 Amylin and bone metabolism in streptozotocin-induced diabetic rats. J Bone Miner Res 16: 958965.
  • 34
    Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre Medhin S, Galson DL, Zajac JD, Karsenty G 2004 Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164: 509514.
  • 35
    Clowes JA, Khosla S, Eastell R 2005 Potential role of pancreatic and enteric hormones in regulating bone turnover. J Bone Miner Res 20: 14971506.
  • 36
    Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C 2003 Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18: 21802189.
  • 37
    Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, Isales CM 2000 Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141: 12281235.
  • 38
    Bollag RJ, Zhong Q, Ding KH, Phillips P, Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R, Isales CM 2001 Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol 177: 3541.
  • 39
    Kong YY, Boyle WJ, Penninger JM 2000 Osteoprotegerin ligand: A regulator of immune responses and bone physiology. Immunol Today 21: 495502.
  • 40
    de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA 2005 Bone mineral density and fracture risk in type-2 diabetes mellitus: The Rotterdam Study. Osteoporos Int 16: 17131720.
  • 41
    Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Zmuda JM, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB, Newman AB, Health ABC Study 2004 Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res 19: 10841091.
  • 42
    Gerdhem P, Isaksson A, Akesson K, Obrant KJ 2005 Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16: 15061512.
  • 43
    Kwon DJ, Kim JH, Chung KW, Kim JH, Lee JW, Kim SP, Lee HY 1996 Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. J Obstet Gynaecol Res 22: 157162.
  • 44
    Isaia GC, Ardissone P, Di Stefano M, Ferrari D, Martina V, Porta M, Tagliabue M, Molinatti GM 1999 Bone metabolism in type 2 diabetes mellitus. Acta Diabetol 36: 3538.
  • 45
    Majima T, Komatsu Y, Yamada T, Koike Y, Shigemoto M, Takagi C, Hatanaka I, Nakao K 2005 Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 16: 907913.
  • 46
    Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T 1993 Bone mineral density measured by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone 14: 2933.
  • 47
    Perez-Castrillon JL, De Luis D, Martin-Escudero JC, Asensio T, del Amo R, Izaola O 2004 Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications 18: 317321.
  • 48
    Dobnig H, Piswanger-Sölkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A 2006 Type 2 diabetes mellitus in nursing home patients: Effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 91: 33553363.
  • 49
    Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW 2003 Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33: 646651.
  • 50
    Schwartz AV, Hillier TA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, Schreiner PJ, Margolis KL, Cauley JA, Nevitt MC, Black DM, Cummings SR 2002 Older women with diabetes have a higher risk of falls: A prospective study. Diabetes Care 25: 17491754.
  • 51
    Williams JP, Blair HC, McDonald JM, McKenna MA, Jordan SE, Williford J, Hardy RW 1997 Regulation of osteoclastic bone resorption by glucose. Biochem Biophys Res Commun 235: 646651.
  • 52
    Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP 2001 Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28: 195201.
  • 53
    Saito M, Fujii K, Mori Y, Marumo K 2006 Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 17: 15141523.
  • 54
    D'Erasmo E, Pisani D, Ragno A, Raejntroph N, Vecci E, Acca M 1999 Calcium homeostasis during oral glucose load in healthy women. Horm Metab Res 31: 271273.
  • 55
    Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, Hata K, Fukumoto S, Matsumoto T 1997 Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 82: 29152920.
  • 56
    Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E 1995 Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 27: 181188.
  • 57
    Baynes KC, Boucher BJ, Feskens EJ, Kromhout D 1997 Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40: 344347.
  • 58
    Schäffler A, Müller-Ladner U, Schölmerich J, Büchler C 2006 Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 27: 449467.
  • 59
    Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100: 197207.
  • 60
    Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305317.
  • 61
    Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G 2005 The molecular clock mediates leptin-regulated bone formation. Cell 122: 803815.
  • 62
    Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT 2001 Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142: 35463553.
  • 63
    Shinoda Y, Yamaguchi M, Ogata N, Akune T, Kubota N, Yamauchi T, Terauchi Y, Kadowaki T, Takeuchi Y, Fukumoto S, Ikeda T, Hoshi K, Chung UI, Nakamura K, Kawaguchi H 2006 Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 99: 196208.
  • 64
    Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL 1999 Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140: 16301638.
  • 65
    Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC 2002 Leptin inhibits osteoclast generation. J Bone Miner Res 17: 200209.
  • 66
    Thommesen L, Stunes AK, Monjo M, Grosvik K, Tamburstuen MV, Kjobli E, Lyngstadaas SP, Reseland JE, Syversen U 2006 Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 99: 824834.
  • 67
    Thomas T, Burguera B, Melton LJ III, Atkinson EJ, O'Fallon WM, Riggs BL, Khosla S 2001 Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29: 114120.
  • 68
    Berg AH, Scherer PE 2005 Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96: 939949.
  • 69
    Kannus P, Sievannen H, Palvanen M, Jarvinen T, Parkkari J 2005 Prevention of falls and consequent injuries in elderly people. Lancet 366: 18851893.
  • 70
    Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, Conzelmann M 2003 Effects of vitamin D and calcium supplementation on falls: A randomized controlled trial. J Bone Miner Res 18: 343351.
  • 71
    Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS 2003 Increased fracture rates in Turner's syndrome: A nationwide questionnaire survey. Clin Endocrinol (Oxf) 59: 8996.
  • 72
    Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino AM, Ranke MB, Rosenfeld R, Silberbach M 2001 Fifth International Symposium on Turner Syndrome. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 86: 30613069.
  • 73
    Horowitz M, Wishart JM, O'Loughlin PD, Morris HA, Need AG, Nordin BE 1992 Osteoporosis and Klinefelter's syndrome. Clin Endocrinol (Oxf) 36: 113118.
  • 74
    Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV 1998 Management of hemochromatosis. Ann Intern Med 129: 932939.
  • 75
    Dittmar M, Kahaly GJ 2003 Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up. J Clin Endocrinol Metab 88: 29832992.
  • 76
    Boscaro M, Barzon L, Fallo F, Sonino N 2001 Cushing's syndrome. Lancet 357: 783791.
  • 77
    Harvey JN, Barnett D 1992 Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf) 37: 97103.
  • 78
    Misra A, Garg A 2003 Clinical features and metabolic derangements in acquired generalized lipodystrophy: Case reports and review of the literature. Medicine 82: 129146.
  • 79
    Delépine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C 2000 EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 25: 406409.
  • 80
    Kipling D, Davis T, Ostler EL, Faragher RG 2004 What can progeroid syndromes tell us about human aging? Science 305: 14261431.
  • 81
    Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR 2006 Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 91: 33493354.